OTC Reform Impact May Be Exaggerated

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

OTC Reform Impact May Be Exaggerated

The impact of reform of the over-the-counter markets on fixed-income revenue may have been overestimated, according to a report by Morgan Stanley and Oliver Wyman.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Related articles

Gift this article